Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POIR: Inhibitory Receptors on T Cells After Lung Cancer Surgery
NCT03549546Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jun 2018
- Primary completion
- Feb 2019
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU Saint-Etienne. Primary endpoint: Expression of PD-1, TIM-3, CTLA4 on CD4/CD8 lymphocytes at Day 3. Started Jun 2018; status: completed.
Beyond the preview
Go deeper on NCT03549546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549546.